Latest drug development News | Page 2

Drug Testing Evolved
New Centre To Be Key In Global AI Medical Research
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Brandon BioCatalyst’s CUREator Incubator Boosts Preclinical and Health Security Biotech Innovations with $1.865 million in funding
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
Noxopharm reports results from Chroma platform drug development program
€1.3M Pre-seed Funding For Lucid Genomics
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
New Chemical Tool Developed For Infection Research
Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of…
Rwanda team visits Addis Ababa for clinical trial training
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
Noxopharm targets clinical trial for first-in-class investigative therapy
AusBioInvest 2024 Keynote Speaker Announced
New Tool PISA-REX Facilitates Drug Development
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
AI accelerates the pace of development of new drugs for brain diseases
Personalised cancer vaccines to be produced at new UQ lab
Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face
Conformational dynamics and allostery elucidate how GPCR couple to multiple G-proteins, offering mechanistic insights into coupling-promiscuity and novel drug discovery strategies
T-cells With License To Kill Viruses
Supercharging Queensland’s Drug Discovery Pipeline
Personalised cancer vaccines to be produced at new UQ lab
NSW Government invests $4.5 million to help reduce and replace animals in medical research
PsiQuantum partners with Queensland universities to advance quantum computing in Australia
Research to make lithium safer for BD patients
NIH Funds Consortium To Speed TB Treatment Development
New Medicines Manufacturing Innovation Centre opens: Monash accelerates medical innovation and development of life-saving treatments
TeraPore uses Cornell research to address virus filtration challenges
Psylo partnership to deliver psychedelic treatments for mental health
DoD grant to fund prostate cancer bone metastases research
Robots Face Future
Childhood cancer detectives embrace open-source AI solution
Study reveals new opportunities to develop cancer treatments
Will we really all die from minor scratches in the future? – Q&A with antibiotic resistance expert
WHO releases report on state of development of antibacterials
Epitope Binning-seq: A Game-Changer in Antibody Drug Discovery Researchers pioneer a novel method, enabling simultaneous analysis of multiple antibodies, revolutionizing drug discovery…
Just 5% of therapies tested in animals end up as as human drugs, new study shows
Vitamin B6: New Compound Delays Degradation
AI plus gene editing promises to shift biotech into high gear
An AI tool for predicting protein shapes could be transformative for medicine, but it challenges science’s need for proof
Progress update on the WHO-US FDA collaborative project on the review and use of online repository for difficult-to-treat infections
Merck Signs MoU with KAIST to Advance Scientific Collaboration
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
Stem cell medicine advancements showcased at reNEW’s scientific meeting
First seizure clinics reduce the need for future healthcare: study
Telix completes proof-of-concept study of TLX592 in prostate cancer
Fighting MND: Backing Great Cause And Great Victorian